Acetylon to receive $4.9 million in funding from Leukemia & Lymphoma Society for Phase I/II trial of ACY-1215 for multiple myeloma

Acetylon Pharmaceuticals Inc.

U.S. / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

The Leukemia & Lymphoma Society

U.S. / Non-Profit or Major Disease Foundation

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced